StonvexLoading…
StonvexStonvexStonvexCore line items from NBR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.18B | $2.93B | $3.01B | $2.65B |
Operating Income | $471.05M | $416.77M | $433.71M | $44.32M |
Net Income | $286.62M | $-176.08M | $-11.78M | $-350.26M |
EPS (Diluted) | $17.39 | $-22.37 | $-5.49 | $-40.52 |
Total Assets | $4.79B | $4.50B | $5.28B | $4.73B |
Total Liabilities | $3.35B | $3.30B | $4.00B | $3.51B |
Cash & Equivalents | $940.71M | $389.65M | $1.06B | $451.02M |
Free Cash Flow OCF − CapEx | $-22.68M | $13.51M | $97.01M | $127.64M |
Shares Outstanding | 14.42M | 9.20M | 9.16M | 8.90M |